News | August 05, 2021
Lyka Labs reports improved set of numbers in Q1FY22
The company has been consistently reducing debt
The company has been consistently reducing debt
The data should be submitted by August 12th 2021
AstraZeneca, Sinopharm and Moderna were part of the study
Arch Pharma Labs has filed the application
The govt has rolled out three schemes for promoting the manufacture of API
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
